Application of nerve guiding factor Sema3A and pharmaceutical composition for treating osteolysis
The invention belongs to the technical field of biological medicine, and particularly relates to application of a nerve guiding factor Sema3A and a pharmaceutical composition for treating osteolysis. By injecting Sema3A overexpressed virus or recombinant Sema3A protein into the tibia of an osteolysi...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!